Beijing Bio-targeting Therapeutics Technology Co., Ltd
Clinical trials sponsored by Beijing Bio-targeting Therapeutics Technology Co., Ltd, explained in plain language.
-
New virus therapy targets advanced breast cancer in early trial
Disease control TerminatedThis early-stage study planned to test a new treatment called BioTTT001, a modified virus designed to attack cancer cells and boost the immune system, combined with standard pre-surgery therapy for women with locally advanced breast cancer. The main goals were to check safety and…
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated May 26, 2026 13:14 UTC
-
Brain cancer patients get virus injection in new hope trial
Disease control ENROLLING_BY_INVITATIONThis study tests a new treatment for people with recurrent high-grade glioma, a serious brain cancer that has come back after standard therapy. The treatment uses a modified virus (oncolytic adenovirus) designed to infect and kill cancer cells while also boosting the immune syste…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Virus therapy takes on hard-to-treat cancers in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called BioTTT001, a modified virus designed to infect and kill cancer cells while boosting the immune system. It involves 12 adults with advanced solid tumors (like head and neck, colorectal, skin, or cervical cancer) who have not resp…
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated May 26, 2026 12:06 UTC